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Abstract
 
Contrary to the general precepts of the clonal selection theory, several recent studies have pro-
vided evidence for the secondary rearrangement of immunoglobulin (Ig) genes in peripheral
lymphoid tissues. These analyses typically used transgenic mouse models and have only de-
tected secondary recombination of Ig light chain genes. Although Ig heavy chain variable re-
gion (V
 
H
 
) genes encode a substantial element of antibody combining site specificity, there is
scant evidence for V
 
H
 
 gene rearrangement in the periphery, leaving the physiological impor-
tance of peripheral recombination questionable. The extensive somatic mutations and clonality
of the IgD
 
1
 
Strictly-IgM
 
2
 
CD38
 
1
 
 human tonsillar B cell subpopulation have now allowed de-
tection of the first clear examples of receptor revision of human V
 
H
 
 genes. The revised VDJ
genes contain “hybrid” V
 
H
 
 gene segments consisting of portions from two separate germline
V
 
H
 
 genes, a phenomenon previously only detected due to the pressures of a transgenic system.
Key words: receptor revision • immunoglobulin heavy chain • variable region • 
recombination • receptor editing
 
Introduction
 
V(D)J rearrangement of Ig and TCR genes has the capacity
to generate an immense repertoire of immune receptors ca-
pable of recognizing virtually any foreign substance (1).
The stochastic nature of this process also results in many
unsuccessful rearrangements or in immune receptors dis-
playing specificity to self-molecules. Lymphocytes with un-
successful VDJ rearrangements can be rescued by contin-
ued rearrangement of the second allele, and for the light
chain loci, the same allele. Similarly, it is now recognized
that in the bone marrow, B lymphocytes displaying self-
specificity can either alter their specificity by further V
gene rearrangement, referred to as receptor editing, or they
are eliminated (2–4). A similar mechanism has been ob-
served for peripheral T lymphocytes (5).
Rather than generating the largest possible nonautoim-
mune repertoire, it is believed that the selective forces act-
ing on mature B cells in the periphery, unlike the bone
marrow, hone the repertoire by selecting only clones with
the highest affinity for antigen, referred to as clonal selec-
tion (6, 7). Central to peripheral selection of B lympho-
cytes is the formation of germinal centers (GCs)
 
1
 
 through
the massive proliferation of antigen-activated clonotypes (8,
9). In GCs, a new round of diversification is initiated by
somatic hypermutation of Ig V genes (10–12). It has re-
cently become evident that the recombination machinery
can also be used to adjust the specificity of clonotypes in
GCs, especially if the repertoire is limited such as in trans-
genic models (13, 14). This peripheral secondary recombi-
nation is apparently diversity driven (15, 16) and has come
to be referred to as “receptor revision” to distinguish it
from the tolerance-driven secondary recombination in the
bone marrow, referred to as “receptor editing” (2–4, 17).
Most work on receptor revision has used transgenic
mouse models to generate examples of the process. To this
point, most examples of receptor revision in the periphery
have involved the light chain locus (15–25). Additionally,
recombination activating gene (RAG) expression and re-
combination intermediates have been detected in GC cells
of both normal mice and humans, suggesting a physiologi-
cal role for receptor revision (15–17, 19, 21, 23, 24), and
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1882
 
Receptor Revision of Immunoglobulin Heavy Chains in Humans
 
several recent studies have suggested a role of this process in
autoimmune disease (18, 19, 25).
Analyses of site-specific transgenic animals carrying V
 
H
 
transgenes with anti-DNA specificity inserted into the J
 
H
 
portion of the endogenous heavy chain locus demonstrated
replacement of the V
 
H
 
 portion of the VDJ transgene by
endogenous 5
 
9
 
 V
 
H
 
 genes using an internal cryptic recombina-
tion signal sequence (RSS) (26). This observation was simi-
larly made in other site-directed transgenic models (27–30),
and previous studies suggested that V
 
H
 
 replacement might
occur in other instances of severely limited repertoire such
as in a B cell lymphoma (31, 32). Although detection of
edited VDJ rearrangements in these experimental systems
suggested that such a mechanism could be active in normal
B cells, the unique nature of the experimental systems left
doubts, and the many years of study have not led to the de-
tection of VDJ editing of previously rearranged heavy
chain genes from normal B cells. It has therefore been a
long-standing question if V
 
H
 
 gene editing plays any role in
the generation of the antibody repertoire.
In this report, clear examples of Ig heavy chain receptor
revision resulting in hybrid V
 
H
 
 genes were cloned from the
tonsil of a normal child. Although primarily found in spe-
cific mature B cell subpopulations, examples of recombined
V
 
H
 
 gene clones were detected in various tonsillar B cell
subpopulations from several individuals. The only revised
VDJ genes detectable by DNA sequencing are formed by
the recombination of two V
 
H
 
 segments in the central por-
tion of the genes. Analysis of the hybrid junctions suggests
that the process is RAG mediated. The formation of hybrid
V
 
H
 
 genes by receptor revision as reported here is a low fre-
quency event that may appear insignificant; however, it
should be realized that these products of recombination are
the only products immediately detectable. Antibody pro-
tein structural constraints will likely preclude the formation
of a functional protein by the combination of portions of
two unique V
 
H
 
 genes in most instances; however, com-
plete V
 
H
 
 or J
 
H
 
 replacements would not be as subject to
such constraints and likely occur at a much greater fre-
quency. However, complete V
 
H
 
 or J
 
H
 
 replacement in a
previously rearranged VDJ gene would be essentially invis-
ible. Additionally, recombination of two V
 
H
 
 elements to
produce nonfunctional proteins may be an important
mechanism for deactivation of one allele and activation of
the second V
 
H
 
 allele; this process would also be essentially
invisible by standard analyses. It is therefore highly signifi-
cant that recombination-generated hybrid V
 
H
 
 genes are de-
tected, as these products of receptor revision are likely only
the tip of the iceberg of the total contribution of receptor
revision of V
 
H
 
 genes to the generation of a secondary im-
mune response.
 
Materials and Methods
 
B Cell Separation Procedures.
 
All B lymphocyte subpopulations
were isolated from normal human tonsils removed during routine
tonsillectomy. The various B lymphocyte subpopulations were
isolated by separation protocols using cell depletion, density gra-
 
dient centrifugation, magnetic bead depletion, and FACS
 
®
 
 based
on the cell surface phenotypes indicated in Table I
 
 
 
as described
previously (12, 33–36).
 
Cloning and Sequencing of Ig V
 
H
 
 Genes.
 
V
 
H
 
4 using VDJ gene
cDNAs was isolated by reverse transcription and PCR of mRNA
from the isolated B cell subpopulations using V
 
H
 
4 family–specific
and isotype-specific oligonucleotide PCR primers as described
previously (34, 37). V
 
H
 
4DJ cDNAs were blunt cloned using ei-
ther pBluescript plasmid vectors (Stratagene) or the PCR-Blunt
cloning kit (Invitrogen), and transformed into 
 
Escherichia coli
 
. V
 
H
 
4
or isotype-positive colonies were detected and picked as de-
scribed previously (34, 37).
 
Isolation of the Recombinant V
 
H
 
 Hybrid Clones.
 
36 clonal pool
1 (CP1) isolates, including 2 of the 7 hybrid recombinants, and
41 CP2 isolates including 1 of the pair of hybrids from CP2 were
cloned at random from a total of 141 IgD
 
1
 
Strictly-IgM
 
2
 
CD38
 
1
 
GC (hereafter IgD
 
1
 
GC) cDNAs from a single tonsil preparation.
Screening colony lifts of the IgD
 
1
 
GC V
 
H
 
4DJ library with CP1
hybrid CDR3, and CP2 CDR3 specific oligonucleotide probes
labeled with 
 
32
 
P produced 29 additional CP1 isolates and 36 addi-
tional CP2 isolates, including the additional hybrid sister clones
from each clonal pool. The CDR3-specific probe sequence (5
 
9
 
-
GGGATCGGGGTGCTTTTGA-3
 
9
 
) used to isolate these addi-
tional CP1 clones spans the DJ junction, and that for the CP2
CDR3 spans the VD junction (5
 
9
 
-AGGCCTCTCGG[A/
G]TA[G/C]TGCA-3
 
9
 
).
 
DNA Sequence Analysis.
 
DNA sequencing was performed on
an ABI-377 automated DNA sequencer (Advanced Biotechnolo-
gies, Inc.). Germline V
 
H
 
 genes for comparison were identified us-
ing the DNAPLOT search components of the VBASE (http://
www.mrc-cpe.cam.ac.uk/imt-doc/, coordinated by I.M. Tom-
linson, MRC Centre for Protein Engineering, 1999) and the in-
ternational ImMunoGeneTics (IMGT [38]) Ig databases. The
background mutation rate for Ig V
 
H
 
 gene analyses attributed to
experimental error was 0.79 mutations per clone (per 300 nucle-
otides) by analysis of 
 
z
 
15,000 C region nucleotides sequenced
along with the V
 
H
 
 genes (each clone consisted of a VDJ gene and
a portion of the C region). Ig V
 
H
 
 gene sequences from this study
are available from EMBL/GenBank/DDBJ under accession nos.
AF262069–AF262209.
 
Computations.
 
Statistical analyses described in the text were
performed using SYSTAT for Windows, Rel. 8.0.0 (SPSS, Inc.).
Phylogenetic analysis was performed using the DNAPENNY
component of the PHYLIP (Phylogeny Inference Package) v3.5c
software (distributed by the author, J. Felsenstein, Department of
Genetics, University of Washington, Seattle, 1993) and was
drawn using TreeView v1.5.2 (39). Software for the detection of
hybrid V
 
H
 
 genes was written for the Microsoft Windows 95/98
platform using Microsoft Visual Basic v6.0 and is available from
the authors for analysis or use.
 
Results
 
In a random cloning of 141 IgD
 
1
 
GC transcripts from a
single human tonsil, 7 VDJ genes contained hybrid V
 
H
 
 seg-
ments that consisted of from 1/3 to 2/3 of their length
from one V
 
H
 
 gene, and the remainder from a second V
 
H
 
gene. Typically in V
 
H
 
 gene analyses, such clones are set
aside, since it is impossible to discern their origin as either a
physiological event or an experimental error that occurred
during the PCR or cloning process due to homology be-
tween the various V
 
H
 
 genes (40, 41). However, 2 of these 
1883
 
Wilson et al.
 
hybrid clones were clonally related to each other and to 33
additional nonhybrid clones and 1 additional unique hybrid
clone, but all were differentiable by their patterns of so-
matic hypermutation. Any set of V
 
H
 
 gene clones isolated
that share CDR3 sequences but are differentiable by the
pattern of somatic hypermutations is considered to have
been derived from the clonal expansion of the same
founder clone during an immune response (clonally re-
lated). In fact, extensive statistical modeling has previously
determined that it is very unlikely that even 2 unrelated B
cells with different CDR3s could occur at random, and 65
or 77 (see below) as in this study is virtually impossible
(42). Additionally, as discussed below, these transcripts
were cloned from the IgD
 
1
 
GC subpopulation, which may
be particularly prone to receptor revision (see Discussion).
To further investigate these interesting clonotypes, oligo-
nucleotide probes were designed that specifically bind the
unique CDR3s from 1 pool of 36 related clones (hereafter
referred to as CP1), and used to screen colony lifts of the
original IgD
 
1
 
GC V
 
H
 
 gene library. Additionally, a second
CDR3 probe was designed to screen a second large clonal
expansion (designated CP2) that contained examples of hy-
brid V
 
H
 
 genes. In this directed cloning, an additional 29
CP1 clones were sequenced of which an additional 5
highly similar hybrid clones were isolated, totaling 7 “sis-
ter” hybrids in a total of 65 CP1 isolates (Fig. 1 A). Simi-
larly, a total of 77 unique clones was sequenced from CP2,
including a pair of sister hybrid clonotypes (see Fig. 2 A).
As depicted in Fig. 1 A, the 7 sister hybrid clones from
CP1 and the consensus of the remaining 57 nonhybrid
CP1 clones (labeled Consensus in the figure) share CDR3
regions consisting of the 3
 
9
 
 end of the V
 
H
 
4-34 gene ele-
ment with the final A residue deleted, an addition of 4 N
nucleotides (GATA), a D3-10 with five 5
 
9
 
 and twelve 3
 
9
 
nucleotides removed by exonuclease activity, and a J
 
H
 
3
gene segment with the first nucleotide removed. A single
hybrid clone from CP1 using a different donor is not in-
cluded in the CP1 consensus but also shares this VDJ junc-
tion. The unique nature of this CDR3 makes it highly
probable that these clones were derived from the same
founder V
 
H
 
4-34/D3-10/J
 
H
 
3 clonotype (42). The 5
 
9
 
 end of
the hybrid sequences to nucleotide position C183 (black
arrowhead) according to the numbering system of Chothia
et al. (43) was derived from the V
 
H
 
4-61 gene element
based on sequence homology (V
 
H
 
4-61 is the bottom se-
quence in the alignments of both Fig. 1, A and B). This re-
gion of the V
 
H
 
4-34 gene segment is easy to differentiate
from V
 
H
 
4-61 because it contains a unique FW1 compared
with all other V
 
H
 
 genes and a six-nucleotide deletion in the
CDR1 (Fig. 1 A).
The junction between the V
 
H
 
4-61 gene–encoded donor
region and the V
 
H
 
4-34 gene–encoded recipient region is
suspected to be a well-conserved cryptic RSS at position
C201 (Fig. 1 A, white arrowhead) shared by both germline
genes in the FW3 after the last position of hybrid homol-
ogy to V
 
H
 
4-61 at C183 (black arrowhead). However, if the
mechanism of recombination turns out not to be RAG
mediated, such as a homologous recombination event, the
region of homology between the V
 
H
 
4-34 recipient and the
V
 
H
 
4-61 donor sequences stretches from position C183 to
C261 and the junction of recombination can be anywhere
in this region. The region of recombination can be further
reduced to the mutated A241 shared by the hybrid recom-
binants and the consensus of the remaining 57 nonhybrid
CP1 clones. Although many somatic mutations are shared
between the seven hybrids, indicating a phylogeny (dis-
cussed below), the individual clones differ from each other
by an average of 22.5 
 
6
 
 9.0 mutations, far exceeding the
background mutation rate determined for this study (Mate-
rials and Methods). This differential mutation indicates
both unique clonality for each of the seven hybrid clones,
and extensive divergence and mutation after the recombi-
nation event.
Similar to the CP1 clones described above, the 72 non-
hybrid clones from CP2 (Consensus in Fig. 2 A) plus the
pair of related hybrid clones isolated share CDR3 regions
consisting of V
 
H
 
4-34, an N nucleotide element (5
 
9
 
-
CCTCTCG-3
 
9
 
), a fusion of a D6-6 D gene with an appar-
ent cryptic D gene identical for a contiguous 10-nucleotide
stretch to a motif 271 nucleotides upstream in the D locus
which is flanked by cryptic RSS (locus information from
reference 44), and J
 
H
 
6 with the first 15 nucleotides re-
moved by exonuclease activity (Fig. 2 A). The pair of hy-
brid sister clonotypes from CP2 were also produced by the
invasion of a V
 
H
 
4-61 germline gene (bottom sequence in
alignment) into a V
 
H
 
4-34 using CP2 recipient at exactly
the same junction as for the CP1 hybrids (position C201,
white arrowheads; Fig. 2 A). In CP2, there were three ad-
ditional hybrid clones isolated, but none of these had a
clonally related sister hybrid to verify their somatic origin.
The pair of sister hybrids from CP2 also shared 12 mutated
nucleotide positions, indicative of their clonality, but they
were differentially mutated far beyond the background
mutation rate (differing at a total of 27 nucleotide posi-
tions), indicating both clonal uniqueness and further muta-
tion after the recombination event (Fig. 2 A).
 
Phylogenetic Analysis.
 
The seven hybrid sequences in
Fig. 1 A are arranged based on phylogenetic similarity from
top to bottom. Based on the shared mutations between
these individual hybrids, they can be grouped into three
subphylogenies after the receptor revision event, including
clones CP1-HB1-1, CP1-HB1-2, and CP1-HB1-3 in one
set, clones CP1-HB1-4, CP1-HB1-5, and CP1-HB1-6 in
a second branch, and clone CP1-HB1-7 as a unique branch
in the phylogeny of the seven recombinants. Based on sev-
eral sequence similarities between CP1-HB1-7 and the
CP1-HB1-4, -5, and -6 subphylogeny, CP1-HB1-7 may
have arisen early on in that branch as well.
The phylogeny of the entire set of 65 CP1 clones is de-
picted in Fig. 1 B and the phylogeny of CP2 in Fig. 2 B.
These analyses were based solely on the regions 3
 
9
 
 to the
proposed recombination junction (nucleotide position
C201, white arrowheads; Figs. 1 A and 2 A) so that differ-
ences between the germline donor and recipient genes in
the hybrid sequences would not effect the outcome. The
seven related hybrid clones (boldface type) from CP1 ap- 
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pear to have been derived relatively early in this phylogeny;
however, it should be noted that all of these clones are ex-
tensively mutated with an average mutation frequency of
29.14 
 
6
 
 6.11 mutations per nonhybrid CP1 clone, and an
average of 19.71 
 
6
 
 3.41 mutations per hybrid clone, indi-
cating that all clones had diverged extensively from the
original V
 
H
 
4-34/D3-10/J
 
H
 
3 founder. Note that all seven of
the CP1 clonotypes were placed in the same branch of the
phylogeny by the DNAPENNY program’s algorithm (see
Materials and Methods), thus verifying that these are sister
clonotypes. In addition, several of the nonhybrid clono-
types share the same branch in the phylogeny demonstrat-
ing the affinity maturation that occurred before the recom-
bination event.
The phylogeny of CP2 in Fig. 2 B indicates that the pair
of sister hybrid clonotypes (CP2-HB1-1 and CP2-HB1-2)
was generated relatively late in the phylogeny, and is part of
a greatly extended branch consisting of over half of the 77
total CP2 isolates. The program’s algorithm also placed
clones CP2-HB1-1 and -2 immediately adjacent to one an-
other, verifying their relation. Based on mutational similar-
ity to the germline V
 
H
 
4-34/D-D fusion/JH6 (and consen-
sus junctional nucleotides), the pair of related hybrid
clonotypes were preceded by at least 21 of the clonotypes
Figure 1. 7 related recombinant hybrids
were isolated from the 65 clones of CP1. A
total of 65 clonally related sequences re-
ferred to as CP1 were isolated by either
random or directed cloning of VH4DJH
transcripts from IgD1GC B cells. The pro-
posed germline genes encoding the CP1
founder clonotype consist of VH4-34, D3-
10, and JH3 (first line of comparisons). Nu-
cleotides homologous to these germline
genes are indicated as dashes. Base ex-
changes resulting from somatic hypermuta-
tion are indicated in boldface type. Asterisks
indicate deletional differences between the
VH4-34 and VH4-61 germline genes. (A) A
comparison of the 7 sister hybrid VH seg-
ments of the revised clonotypes with the
consensus sequence of the remaining unre-
vised 57 CP1 clones (second line) and with
the VH4-34 (top line) and VH4-61 (bottom
line) germline genes. Another single CP1
hybrid that used a different donor VH gene
than the seven sister hybrid clones is not
shown or included in the consensus. The
last nucleotide of homology of the hybrids
to VH4-61 is C183 (black arrowhead).
Proximal to C183 is a well-conserved cryptic RSS beginning at C201 that we
propose is the hybrid junction. A canonical heptamer-nonamer RSS is included
for comparison, and the white arrowhead marks the proposed junction. The
seven hybrid clones are listed from top to bottom in order of phylogenetic simi-
larity. Note the last three lines of the sequence comparison, demonstrating the
undoubted clonal relatedness of the hybrid clonotypes to the rest of the CP1 iso-
lates represented by the consensus. Ig sequence numbering is based on the num-
bering system of Chothia et al. (reference 43). (B) Phylogeny of CP1. This phy-
logenetic tree is the most parsimonious tree implied using the “branch and
bound” algorithm of this DNAPENNY component of the PHYLIP phyloge-
netic analysis software package (see Materials and Methods). The tree is rooted
on the germline VH4-34/D3-10/JH3 genes with consensus junctional regions
(indicated by the boxed “CP1 Germline”), and was produced using only the 39
end of the VH genes beyond the point of the proposed hybrid junction (white
arrowhead at C201 in A) in order to negate effects of the 59 portion of the hy-
brid sequences (composed of VH4-61) on this comparative analysis, and allowing
an estimation of when the receptor revision event occurred during the develop-
ment of this clonal pool. The “Consensus” sequence in A is based on the major-
ity sequence of all of the clones in normal print on this tree. The seven hybrid
sequences from this figure are indicated in boldface type. Note that the receptor
revision event apparently occurred quite early in the phylogeny; however, as
discussed in the text, it should be noted that all clones were highly diverged
from the germline VH4-34/D3-10/JH3 sequence of the original CP1 founder. A
second hybrid involving a different 59 VH donor from this clonal pool (CP1-
HB2, underlined) also occurred early in the phylogeny.1885 Wilson et al.
in this branch alone, and share several somatic mutations
with clones in divergent branches of the tree as well. As
discussed below, this phylogeny is of extreme interest, as it
suggests that the recombination event generating these
clonotypes occurred after the process of somatic hypermu-
tation was initiated, and that somatic mutation then contin-
ued after the event.
Specific Nucleotide Changes Provide Evidence That Receptor
Revision Occurred during Affinity Maturation. The shared
VDJ junctions between the 7 hybrid clones of 58 total CP1
clones and the 2 related hybrids of 77 total CP2 isolates in-
dicate with certainty that there was recombination of do-
nor (VH4-61) sequence into the respective recipient VH4-
34 founder sequence for at least 2 separate clonotypes.
However, the detection of the products of recombination
alone does not indicate the stage of B cell differentiation
when these events occurred, although the phylogenetic
analyses above are quite suggestive of recombination dur-
ing affinity maturation. It is highly unlikely that these hy-
brid recombinants were formed in the bone marrow during
normal B cell development and recombination, as the
IgD1GC population analyzed has such extensive clonal ex-
pansion and somatic hypermutation. Additionally, a careful
analysis of the particular nucleotide positions mutated
greatly enhances this hypothesis. 2 mutated positions in the
CP1 sequences, A243 to T and G276 to T, are shared
among the majority of the 57 nonhybrid clones, the single
unique hybrid clone, and all 7 sister hybrid CP1 clones in
the postrecombinational junction region after C201 (ar-
rowheads in Fig. 1 A). Even more telling are the postjunc-
tional mutations shared by the pair of CP2 sister hybrids
with the remaining 72 CP2 isolates (Fig. 2 A). Note that
not including the D gene elements and junctional regions,
there are 8 positions similarly mutated between the pair of
CP2 isolates and the consensus of the remaining 72 nonhy-
brids (the 3 additional hybrids not related to the pair in Fig.
2 were not included).
It should also be realized that the consensus sequences
represent only the majority sequence identity at each nu-
cleotide position, and that there is a minority of the re-
maining mutated positions on the nonhybrid clonotypes
that are also shared with the postjunctional regions of their
respective CP1 and CP2 hybrid counterparts. Similarly,
there is a minority of nonhybrid clonotypes from either
pool that do not share many of these mutated positions, in-
dicating that these alterations are not simply polymorphic
Figure 2. A pair of related hybrid recombinants with extensively mu-
tated postjunctional regions were isolated from 77 total clones of CP2. All
labeling, annotations, and methods are standardized to Fig. 1. “Consen-
sus” in the second line in A of the comparison represents 72 nonhybrids
from this clonal pool, which are displayed in normal print in B. Three ad-
ditional single hybrid VH isolates in this clonal pool are not included in
the consensus, but are underlined in the phylogeny in B. Note the eight
somatic mutations shared by the two hybrid recombinants and the con-
sensus of the nonhybrids in the postjunctional regions (after C201, white
arrowhead) of VH4-34 and JH6. These mutations are highly indicative that
somatic hypermutation had begun before the hybrid formation, and addi-
tional mutations 59 to the junction demonstrate continued hypermutation
after the hybrid formed. A similar point is evident by the phylogeny of
the postjunctional portions of all CP2 clones in B. The hybrids occur in
the middle of an extensive branch of the phylogeny, indicating muta-
tional divergence both before and after the recombination event. It is in-
teresting to note that another single hybrid recombinant (CP2-HB2, un-
derlined in B) formed with a different donor gene (VH4-39 donor)
occurred immediately after the pair of related hybrid recombinants dis-
played in bold print (CP2-HB1-1 and CP2-HB1-2).1886 Receptor Revision of Immunoglobulin Heavy Chains in Humans
variation of the VH4-34 gene used by the different clono-
types. One drawback to working with human specimens,
especially rare cell populations such as these IgD1GC cells,
is that there is limited availability and therefore direct anal-
ysis of this patients genomic VH4 repertoire could not be
done to verify that these mutations were not due to poly-
morphism. However, the fact that we had cloned and se-
quenced 230 VH4-34 cDNAs from this individual allowed
us to prove unquestionably that the nucleotide positions al-
tered resulted from somatic hypermutation. Of these 230
VH4-34 using clones, 176 could be placed within 14 clonal
expansions, and the remaining 54 had unique CDR3s, thus
totaling 68 unique VH4-34 clonalities. Although there were
particular mutational similarities in the various clonal ex-
pansions, there were no consensus positions matching the
postjunctional mutations of the consensus CP1 and CP2
clonotypes. In fact, the expected mutation rate for this sub-
population, which averages 21.90 6 8.92 mutations per V
gene sequence (300 nucleotides), is 21.90 6 8.92 per 300
nucleotides, equating to a 4.3–10.3% chance of each posi-
tion being mutated at random. Of the 2 CP1 and 8 CP2
postjunctional consensus mutations that might be polymor-
phic variations, only the G at position 276 was found mu-
tated in .10.3% of the 68 unique clonalities from this ton-
sil; however, the mutation frequency for this position was
only 12.5% and therefore quite insignificant (x2 probability
approaches 1.0). The lack of related sequences in other
VH4-34 clonalities of this tonsil donor is highly suggestive
that these nucleotide alterations arose somatically. As a sec-
ond test of whether these mutations could have arisen via
polymorphic variation as opposed to somatic hypermuta-
tion, a comprehensive search was performed of both our
own extensive database of VH4 family genes, including 456
unique clonotypes using VH4-34, and extensive searches of
the IMGT, VBASE, and Kabat Ig databases and GenBank
for VH4-34 polymorphic variants resembling the mutated
consensus sequences of CP1 and CP2. The overwhelming
conclusion is that these clonotypes resulted from somatic
hypermutation, not polymorphic variation. The fact that
the nucleotide alterations demonstrated in the postjunc-
tional regions were both progressively accumulated, as in-
dicated in the phylogenetic analyses, and were undoubtedly
generated somatically is an important observation as it
places the timing of the recombination events during on-
going somatic hypermutation.
VH Gene Hybrids Can Be Found in Other B Lymphocyte
Subpopulations. Over a period of several years, we have
cloned .700 full-length VH4(D)J transcripts from several
different tonsils, B cell subpopulations, and isotype com-
partments (Table I). After finding evidence that VH gene
hybrids are somatically generated in the IgD1GC subpopu-
lation, a computer program was written to analyze VH
genes on a nucleotide by nucleotide basis for sequence re-
gions more similar to another germline VH gene than the
sample sequence’s nearest germline counterpart. The pro-
gram compares any region ,100% similar to the proposed
nearest-fit VH germline gene to every human VH gene
clone in the VBASE and IMGT Ig databases. In this analy-
sis, 14 additional transcripts appeared to be hybrid VH gene
recombinants, including an additional CP1 clone with a
Table I. Comparison of Various B Cell Populations Compiled from Tonsils of Four Individuals*
B cell subpopulation
(no. of clones)
Tonsil
donor
Cell surface
phenotype‡
Somatic
mutation§ Percent clonalityi JH6 usage¶
Hybrid
frequency**
%% %
Follicular mantle (35) 1 IgD1IgM1CD382 0.08 6 1.11 None 15 None
IgM GC precursors (94) 3 IgD1IgM1CD381 3.29 6 3.45 22 (1 pool) 20 2.1 (2)
IgD1GCs (141[240])‡‡ 3 IgD1IgM2CD381 21.90 6 8.92 77 (14 pools) 50 5.0 (7)
IgM GCs (145) 1, 2 IgD2IgM1CD381 6.51 6 5.81 28 (10 pools) 10 2.0 (3)
IgG GCs (146) 1 IgD2IgM1CD381 14.96 6 8.37 14 (10 pools) 10 None
IgM memory (60) 1, 2 IgD2IgM1CD382 4.46 6 5.51 None 7 1.6 (1)
IgG memory (72) 1 IgD2IgM1CD382 14.48 6 8.72 None 13 None
IgM plasma cells (29) 2 IgM1CD3811CD20low 4.69 6 3.81 41 (6 pools) 29 3.4 (1)
*JH6 usage and frequency of somatic hypermutation are consistent with previous publications (references 12, 33, 49).
‡Cell surface phenotypes of the various B lymphocyte subpopulations analyzed as described previously (references 12, 33–36).
§Mean number of mutations per VH segment of each clone analyzed minus the error rate (see Materials and Methods) 6SD.
iClonality is defined as clones sharing identical HDJ junctions (CDR3s), but which are differentially mutated to a degree greater than the back-
ground mutation rate (see Materials and Methods) determined for the VH gene C regions. A clonal pool (parentheses) is a set of clonally related VH
genes based on CDR3 similarity as described in the Results.
¶For this analysis, each pool of clonally related transcripts is counted as only one instance of JH6 utilization.
**Percentage of total clones (number of hybrids): this includes only revised VH genes cloned at random, not hybrids isolated by directed cloning as
described in the text.
‡‡240 total isolates from this population were sequenced and used to produce the average mutation frequency as mutation could act equally on all
clones; however, the remaining analyses were based solely on the 141 isolates that were randomly cloned.1887 Wilson et al.
hybrid VH gene but derived from recombination with a
different germline gene than VH4-61 (the donor is VH4-
39), and 3 additional unique CP2 hybrids (1 with a VH4-61
donor but a different junction, a second with a VH4-30.1
donor, and a third with a VH4-39 donor). 12 of 14 of the
additional hybrid VH clones isolated contained mutations
comparable to the B cell subpopulation from which they
were isolated, suggesting a peripheral origin for most of
these recombinants as well. As indicated in Table I, the
greatest number of hybrid VH sequences was isolated from
the IgD1GC subpopulation. Although the only population
to which VH hybrid detection could be statistically linked
is the IgD1GC subpopulation (.95% confidence based on
Pearson correlation analysis), hybrid clones were detected
in all other populations except the naive follicular mantle
cells and, surprisingly, the IgG1 subpopulations analyzed.
The inability to find VH hybrid recombinants in the 146
IgG GC and 72 IgG memory B cell transcripts analyzed is
likely due to the low frequency of these events. It should
be noted that these additional hybrid VH sequences identi-
fied were single, unique isolates and therefore have not
been irrefutably proven to be the products of a recombina-
tion event as for the seven recombinants of CP1 and the
pair from CP2. However, it is unlikely that these tran-
scripts are polymorphic variants that have never before
been isolated, as they were cloned only one time in our
analyses of many transcripts from each of the individuals
and have never been isolated in the thousands of VH genes
analyzed in this and other laboratories in the past. It is also
unlikely that these events arose as errors of the experimen-
tal system, as they all formed apparently functional clono-
types.
Cryptic Recombination Sequences Are Found at the Hybrid
Junctions. A striking observation in our study was the de-
tection of cryptic RSS in proximity to every junction of
every hybrid isolated, even when the region of similarity in
which the junction could occur only consists of six nucle-
otides (Fig. 3). Granted, our definition of a cryptic RSS is
minimal in that it has been shown that the minimal se-
quence requirements of an RSS is the 59 CAC (or inverse
39 GTG) of the canonical heptamer (45), and several of the
proposed heptamers contained only this trinucleotide. Of
particular interest is that the proposed junction used by the
seven sister hybrids from CP1 is also the best junction for
the CP2 hybrid sisters and one other single recombinant
isolated (Fig. 3, Set 1). For the junction in Set 1, there are
4/7 conventional heptamer nucleotides, including the
obligatory CAC motif, and if a spacer of 13 nucleotides
rather then 12 or 23 is used, there are 7/9 conventional
nonamer nucleotides. The canonical 12-bp RSS is com-
monly considered as 12 6 1 bp (45), and so this RSS is
nearly ideal. Another cryptic heptamer junction was used
by four separate recombinant hybrids isolated in three sepa-
rate cloning experiments (Fig. 3, Set 2). Two hybrid clones
isolated use a third junction (Fig. 3, Set 3), and the remain-
ing six are all unique. Another recombinant of particular
interest is CP1-HB3, which contains a GTG motif at the
junction followed by a deletion of 24 nucleotides (8 amino
acids), leaving the gene in frame. This deletion is within
the CDR2 region of the VH gene, which is a hypervariable
region and structurally quite flexible. We and others have
demonstrated previously that in these hypervariable loops
large insertions and deletions can be tolerated by immuno-
globulins (34, 46, 47). This observation suggests exonu-
clease activity at the hybrid junction.
Figure 3. There are cryptic RSS at each of the VH recombinant hybrid
junctions. For each comparison, the germline counterpart of the original
or recipient VH gene is the top sequence, the bottom sequence is the germ-
line donor VH gene, and the middle sequence is the hybrid VHDJ clone.
Nucleotides similar to the recipient VH gene are shown as dashes. Standard
RSS containing both 12- and 23-bp spacer segments are listed at each
junction for reference (the short RSS for Set 1 uses a 13-bp rather than a
12-bp spacer, as this spacer length gives a more complete nonamer; the ca-
nonical 12-bp spacer is actually 12 6 1 bp [reference 45]). Three of the
cryptic RSS were shared by greater than one hybrid VHDJH clone isolated
(listed as Set 1‚ Set 2, and Set 3). The remaining six isolates had unique
junctional positions. Note that clone CP1-HB3 has a 24-nucleotide (8-
codon) deletion suggestive of exonuclease activity during recombination.
Complete Ig VH gene sequences from this study are available from
EMBL/GenBank/DDBJ under accession nos. AF262069–AF262209.1888 Receptor Revision of Immunoglobulin Heavy Chains in Humans
RAG-mediated Recombination Intermediates Could Not Be
Detected. Although intermediates of recombination re-
sembling those expected in the formation of hybrid VH
genes have not been conclusively detected to date. These
intermediates may be exceedingly rare and there are many
inherent difficulties in working with GC cells for tech-
niques designed to detect the free DNA ends produced by
recombination such as ligation-mediated PCR, due to the
propensity of these cells to apoptosis and DNA degrada-
tion. Despite significant effort to identify the expected re-
combination intermediates in the form of double-strand
DNA breaks at the proposed recombination junctions by
ligation-mediated PCR (48), we have been unable to con-
clusively demonstrate these intermediates at this point (data
not shown). Additionally, the IgD1GC cells in which we
detected a particular propensity to carry recombinant hy-
brid VH genes have been characterized as most like centro-
blasts (49), which it has been demonstrated do not express
the RAG proteins (16, 50); however, the IgD1GC cells
have not been tested directly. We have some evidence that
a sorted IgD1GC isolate expresses RAG transcripts; how-
ever, two factors make this information inconclusive: (a) it
is not clear if these IgD GC cells have a centroblast
(CD381CD771) and a centrocyte (CD381CD772) com-
ponent due to the requirement of a four-marker analysis
(CD38, CD77, IgD, and IgM); and (b) this population typ-
ically represents only z1% or less of tonsillar B cells.
Finally, a set of PCR experiments was performed in an
attempt to detect the predicted deletion circles of hybrid
joint recombination. PCR primer binding sites for the
most frequently observed hybrid recipient (VH4-34) and
donors (VH4-61 and VH4-39) were designed as depicted by
the small arrows in Fig. 4 a. It should be noted that standard
PCR amplification is particularly prone to generate false
positive products for these analyses, presumably because of
the linear amplification of single stranded, complimentary
copies of the donor and recipient genes during the early
rounds of PCR due to the abundance of “normal” (noncir-
cle) template (see the asterisk in Fig. 4). For example, a
PCR using these primers on a recombination-negative
population of 500,000 cell equivalents of DNA would pro-
duce 30,000,000 single-stranded reverse compliments of
the two donor alleles and the recipient alleles that could
very easily combine at regions of homology to form what
appears to be a deletional circle product. This indeed was
the case: after multiple trials on various cell populations that
are recombination competent or not, we found that appar-
ent recombination circles could be amplified from every
population; however, none of these products were somati-
cally mutated in the recipient half, and the junctions were
typically not at cryptic RSS. To improve this technology,
we first used a biotinylated primer specific for the recipient
gene (the right primer in Fig. 4, below the asterisk) in a
one-cycle extension step using Taq polymerase to produce
biotinylated template that must contain the 59 untranslated
region (UTR) of the recipient. We then captured this tem-
plate using streptavidin beads and washed away all remain-
ing remnants of nonbiotinylated DNA. This template was
then amplified by PCR using an internal primer for the 59
UTR of the recipient gene, and a primer specific for the
donor 39 UTR. Using this technique, we eliminated all
false positive amplification products, while retaining ampli-
fication using a pair of recipient-specific primers as a posi-
tive control. These experiments also failed to detect the ex-
pected recombination circles (negative data not shown),
leading to the conclusion that as discussed below, it may be
impossible to isolate heavy chain recombination intermedi-
ates from the currently known GC cell phenotypes isolated.
Figure 4. VH to VHDJH recombination
requires hybrid joint formation. RAG-medi-
ated cleavage occurs at the RSS producing
signal ends (triangles) and coding ends (short
rectangles). (a) To produce a functional hy-
brid recombinant, nonstandard V(D)J re-
combination involving hybrid joint forma-
tion with coding to signal end joining must
occur (reference 26). Joining of the recipi-
ent signal end to the donor coding end pro-
duces a functional VH gene consisting of 59
donor sequence and 39 recipient and DJH
sequence. The end of the original VHDJH
gene 59 to the internal cryptic RSS, and the
end of the donor VH gene 39 to its internal
cryptic RSS, plus any intervening DNA,
form a circular deletional product by donor
signal end to recipient coding end joining.
(b) Standard V(D)J recombination involves
signal to signal end, and coding to coding end joint formation. If standard recombination were to occur involving a VH to VHDJH recombination, the do-
nor signal end and 39 donor sequence would be joined to the recipient signal end and 39 sequence, forming a nonfunctional hybrid consisting of the in-
verted 39 end of the donor recombined to the recipient 39 end DJH. Recipient to donor coding end joining would similarly disrupt the donor VH gene
sequence. Note that this inversional recombination would not damage the chromosome and may be a means to deactivate rearrangements allowing rear-
rangement at the other allele, as suggested by Taki et al. (reference 27). As described in the text, the small arrows in the top panel marked by an asterisk
mark the position bound by primers to specifically detect the recombination circle deletion product. Note that only in the deletion circle will these prim-
ers drive an efficient reaction.1889 Wilson et al.
Discussion
Lack of Recombination Intermediates
There is the distinct possibility that heavy chain recom-
bination activity may only occur in GC cells exhibiting a
differential phenotype not included with typical isolates.
This is particularly true for the IgD1GC cells that we iso-
late based on IgD and CD38 surface expression and the
lack of IgM. It would not be expected that heavy chains
being actively rearranged would display surface Ig, and
therefore our sorting strategy would fail to collect the re-
combinationally active cells. Furthermore, the impetus to
rearrange the heavy chain genes may be loss of functional
heavy chain due to mutational damage. It is also certainly
feasible that GC cells lacking Ig will take on a differential
phenotype. The previous examples of RAG protein ex-
pression in centrocytes only detected recombination inter-
mediates of light chain origin in combination with surro-
gate light chain expression (16); heavy chain recombinants
may simply not look like normal GC B cells, and therefore
may not be found when standard isolation strategies are
employed. Therefore, the lack of detection of the hallmarks
of recombination is not particularly surprising, and the ver-
dict must still be out on the issue of RAG mediation.
The Ideal Substrate: IgD1GC B Lymphocytes
The IgD1GC B cell subpopulation is of tonsillar origin
and displays the interesting phenotype of having undergone
a Cm-Cd isotype switch, and is therefore strictly IgD single
positive (36, 51). In this analysis and/or as suggested previ-
ously (36), IgD1GC cells display several characteristics that
make them uniquely suited for both the occurrence and
detection of V genes altered by receptor revision.
First, IgD1GC cells display 90–99% l light chain usage
(33, 49, 51), whereas the expected light chain utilization
for humans is a 2:1 ratio of k over l light chains (52). De-
tection of light chain recombination intermediates, as well
as increased l usage have been correlated to receptor edit-
ing and revision (15, 16, 21, 23, 24).
Second, IgD1GC cells display an uncommonly high fre-
quency of somatic hypermutations (33, 49). The 240
IgD1GC VH transcripts that we cloned averaged at least 1.5
times more mutations per clone then any of the other 7
mature B cell subpopulations analyzed (Table I). This high
level of mutation could be related to increased receptor re-
vision in several ways. First, the extremely large number of
base substitutions could introduce excessive amino acid
changes, disrupting the VDJ tertiary structure or introduc-
ing stop codons. Receptor revision could be a means to
rescue these damaged clones. Second, the extensive clonal-
ity of IgD1GC cells (discussed below, and see Table I) sug-
gests that this population displays limited diversity and
could therefore be driven to diversify its VH genes to a
much greater extent than other GC cells by both mutation
and rearrangement. Finally, as discussed by Liu et al.,
IgD1GC cells may be sequestered in the GC environment
for prolonged lengths of time and therefore excessively
subjected to the somatic mutation machinery (33). A simi-
lar prolonged exposure to factors stimulating recombina-
tion could also occur. Finally, as discussed below, we
present a model in which the process of somatic hypermu-
tation may be directly involved in the generation of the hy-
brid recombinants.
Third, IgD1GC cells have a much higher propensity to
use the JH6 gene segment than any other B cell subpopula-
tion analyzed (33, 49; Table I). This increased JH6 usage
could result from receptor revision of already rearranged
VDJ genes by downstream JH6 genes, as JH6 is the most 39 JH
gene segment. This mechanism can be envisioned as analo-
gous to the VH hybrid generation demonstrated here, al-
though we have no evidence yet for this occurrence. A sec-
ond possibility is a V(D)J rearrangement involving cryptic D
elements within the V locus upstream to the original rear-
rangement that recombines with JH6, and then to an up-
stream VH gene segment, thus deleting the original VDJ re-
arrangement. Interestingly, we have performed extensive
searches of the published sequence of the human VH locus
(44) for better fits to D elements used in the JH61 IgD1GC
clonotypes and found several 8–16-nucleotide-long matches
with sequences within the VH portion of the locus. These
“cryptic Ds” typically had at least one believable RSS proximal,
for example: clone 1, 59-GGGGAACATCACACACTGG-
GTCCTGTCATGGGGTGGGGGTAGTGGGGAGGGA-
TACCATTAGGATATATG-39; clone 2, 59-TTTAAACT-
CCCGATTCCTACTCTCAGTGGGAGGGAATCACA-
GCCAATCACACATCACAGGACAAATCTGTAAAC-39;
and clone 3, 59-TGTCCATGGTGGATGTGTGGTGTG-
GGTGTCTGTGTCTATTTCTGTTTACTCTGCTTGA-
GGTTCTCTGTGATTCTAGGATCTGTAGTTCAGT-
GTC-39. The underlined segment is the region of identity
with a D element in a JH61 clone for which no known D
germline gene could be assigned. The proposed cryptic
RSS are in boldface. The germline VH gene for all three
clones is VH4-34 and is located 129 kb 59 in the human VH
locus from clone 1, 289 kb upstream of clone 2, and 308 kb
upstream of clone 3. All of these segments are located well
upstream of the D genes within the VH region. Although
these observations are intriguing, we have as yet no direct
evidence that these elements are truly recombined to VH and
JH genes. Secondary rearrangement of JH gene segments in
the periphery was previously suggested by a report of JH
gene recombination signal breaks from peripheral B cells of
a transgenic mouse model stimulated with LPS and IL-4 in
vitro (24).
And finally, IgD1GC cells display an uncommonly high
number of clonally related sequences (77–83%, Table I; 33,
49). This high level of clonality allows the unambiguous
detection of revised VDJ rearrangements as clones within a
single clonal pool (sharing VD and DJ junctions, but with
different VH genes).
VH Locus Considerations for Recombination by Receptor Revision
Donor VH genes 59 in the locus are a prediction of re-
ceptor revision involving VH to VHDJ recombination be-1890 Receptor Revision of Immunoglobulin Heavy Chains in Humans
cause all 39 VH elements between the recipient VH and the
D gene are deleted during the original V(D)J recombina-
tion. In Fig. 3, the recipient VH gene is the top sequence of
each comparison. Surprisingly, 8 of the 15 hybrids detected
involved donors located 39 to the recipient genes according
to available VH locus maps. However, it should be realized
that there are essentially only two complete VH loci
mapped and these maps differ significantly in both VH gene
content and gene positions (44, 53, 54). Additionally, par-
tial maps and other analyses of various alleles have detected
many allelic variations between VH loci (55). Nothing short
of mapping additional VH loci will address this discrepancy
adequately and considering that the couple of loci currently
available took many years to produce, such experiments are
impractical and beyond the scope of this report. Another
less likely possibility also exists in that there is evidence of
second allele reactivation during receptor revision (24), and
therefore recombination could occur using a transallelic
donor VH gene. Transallelic recombination for VH to VHDJ
revision is physically possible, as this process requires the
production of either a hybrid recombination joint (dis-
cussed below, and see Fig. 4) or a homologous recombina-
tion event leaving both chromosome 14 alleles intact, but
with exchange of the 39 ends of the chromosome pair from
the point of the recombination junction.
The current study used PCR primers specific for the
VH4 gene family and therefore all of our examples were
formed of VH4 gene family donors and recipients. The
seven human VH gene families are differentiated based on
80% or greater homology between genes within each fam-
ily. There is no reason to believe that VH genes from other
families don’t also recombine in a similar fashion. It is
doubtful however, due to protein structural constraints that
hybrid VH recombinants could form between two VH
genes that are highly divergent, such as between two differ-
ent VH families where at least 20% (and typically more) di-
vergence exists, and still retain some semblance of their an-
tigen-binding surface. As little as a single amino acid
alteration can have drastic effects on the binding surface on
an antibody, and 20% variation in the primary structure is
likely disastrous (Edmundson, A., personal communica-
tion).
Frequency of VH Gene Editing
There are several factors that make it difficult to deter-
mine a true frequency of receptor revision and its impact
on the V gene repertoire in the periphery. Clones in which
a successful internal rearrangement occurred forming a hy-
brid VH clone are most easily identified, as rearrangements
using the conserved cryptic heptamer at the 39 end of the
VH gene, reminiscent of the VH gene editing observed in
the autoimmune transgenic mouse models, would be un-
detectable in most instances (26, 31, 32). Similarly, replace-
ment of JH gene elements as suggested by the significantly
increased JH6 gene usage in the IgD1GC population (dis-
cussed above) relative to the other subpopulations (Table I)
would be invisible to standard sequence analyses. Addition-
ally, as suggested by Taki et al., based on observations in
their transgenic model of VH gene receptor editing, VH to
VDJ rearrangements may be more important as a means to
deactivate one allele, allowing recombination to initiate on
the second allele (27). As indicated in Fig. 4 A, hybrid VH
gene production requires nonstandard hybrid joint recom-
bination as opposed to standard recombination. It has been
demonstrated that RAG protein activity results in only 5%
of this nonstandard recombination activity and 95% stan-
dard recombination (56). It is therefore probable that if
RAG mediated, the bulk of the activity of receptor revi-
sion is to deactivate the current allele, allowing for second
allele rearrangement as demonstrated in Fig. 4 B. There are
reports of second VH allele activation in the spleen of two
transgenic systems (24, 30). Second allele activation would
also be undetectable by previous experimental approaches.
Thus, peripheral recombination of VH genes to form hy-
brid VHDJ genes is probably a minor product of receptor
revision; the bulk of the activity of this process and its im-
pact on the antibody repertoire is likely much greater. Sev-
eral experimental approaches are being followed to access
the true frequency of receptor revision of Ig VH genes.
Two Possible Mechanisms of VH Hybrid Formation: RAG
versus Not-RAG
Revision of the rearranged VHDJH genes by VH gene re-
placement is a documented process of receptor editing in
the bone marrow as a mechanism to alter autospecific
transgenes (26, 27). Chen et al. (26) suggested that this pro-
cess was RAG mediated, but nontraditional in that “hy-
brid” rather than standard recombination joints would have
to be formed in order to produce functional VH genes (Fig.
4). Nontraditional joints including hybrid joints and
“open-and-shut” joints have been shown to occur at a low
frequency in normal V gene rearrangement both in vitro
and in vivo (56–60). Both joints involve cleavage at the
heptamer signal, followed by signal to coding end joining,
as opposed to signal–signal and coding–coding joint forma-
tion as in normal recombination. Open-and-shut recombi-
nation joins the coding and signal ends of a single substrate,
essentially reversing the cleavage reaction, whereas hybrid
joints involve the joining of the signal end of one RSS to
the coding end of the second (Fig. 4). A great deal of in-
sight into the formation of hybrid joints has been gained
recently that provides important modifications and en-
hancements to this model.
The Ku proteins (Ku70 and Ku86) form a heterodimer
that is important for the activity of DNA-PKCS, which in
turn plays a central role in DNA double-stranded break re-
pair and is necessary for proper V(D)J recombination (61).
Recent work has demonstrated that in Ku and DNA-PKCS
deficient systems, although normal recombination is essen-
tially absent, the formation of hybrid joints and open-and-
shut joints is nearly normal (59, 60). In fact, only the RAG
proteins and HMG1 are required to form these nonstand-
ard joints in vitro (57). The demonstration by Lewis and
Hesse that the recombination machinery can produce
open-and-shut joints on several different substrates, includ-1891 Wilson et al.
ing noncanonical signal sequences, single RSS substrates,
and paired 23–23 substrates, have led to the hypothesis that
this activity of the recombination machinery acts to reverse
the cleavage reaction as a last ditch effort to circumvent im-
proper cleavage (58). Additional support for this hypothesis
derives from the observation that in the open-and-shut
joints and hybrid joints produced in Ku-deficient systems,
although some P nucleotide addition is present, there is a
lack of N nucleotide addition and reduced exonuclease ac-
tivity (60). Limiting junctional diversity would be ideal for
the repair of inappropriate cleavages.
Model 1: RAG-mediated Hybrid VH Gene Formation. The
nonstandard joint-forming activity of the recombination
machinery could be driven toward hybrid joint forma-
tion rather then open-and-shut joint formation when the
substrates are the cryptic heptamers found within a pair of
V gene coding sequences. Normal recombination might be
inhibited by the cryptic nature of the RSS through disrup-
tion of the normal synaptic complex, and therefore the
only reaction possible by the RAG proteins would be non-
standard joint formation. Additionally, the fidelity of these
joints as described above would allow the formation of
functional VH genes upon revision. The homology be-
tween the pair of recombinants in VH to VH recombination
may help drive hybrid joint formation. In this model, in-
volvement of the recombinase may serve only to bring the
donor VH gene element and the recipient VDJ gene into
proximity with cleavage of one of the substrates to initiate a
homologous recombination event. It is feasible that the re-
combination machinery has evolved so that not only can it
repair its own mistakes, as suggested by the formation of
open-and-shut joints, but it can also serve in different ca-
pacities of recombination such as VH gene hybrid forma-
tion, either directly or through facilitation. We are cur-
rently exploring the recombinational capacity of the cryptic
RSS found within the VH4 genes described.
Model 2: Non-RAG–mediated VH Hybrid Formation. Two
intriguing recent studies using green fluorescent protein
(GFP) transgene constructs to mark RAG-2 gene ex-
pression throughout a B cell’s life span have generated
some intriguing insight into peripheral receptor editing (62,
63). These studies suggest that RAG protein expression is
not actually reinduced in GC cells, but rather is perpetu-
ated from the bone marrow. Adoptive transfer studies in
the report from Yu et al. indicated that only cells that were
RAG1 before transfer could be induced to rearrange their
V genes (62). These studies suggest that rather than rein-
duction of RAG protein expression in the GC environ-
ment, proper stimulation upregulates the recombination
machinery only in cells where RAG expression is already
present at basal levels. The authors of both reports sug-
gested models of increased bone marrow cell migration
into the GC environment after immunization.
The findings of the current report suggest extensive
clonal expansion and somatic hypermutation both before
and after the recombination of VH genes. Also, RAG ex-
pression would have to perpetuate through multiple cell
divisions, which is potentially disastrous if recombination
breaks are present during mitosis. In addition, there is re-
cent evidence that cell cycle regulators control RAG-2 ac-
tivity before the synthesis phase of mitosis, and therefore
continued RAG gene expression during a clonal expansion
is not likely (48, 64–66). These observations in addition to
our inability to conclusively demonstrate the predicted
heavy chain recombination intermediates leave the distinct
possibility that the recombinational activity observed may
not be RAG mediated.
An intriguing possibility is that these events result from
the activity of the somatic hypermutation machinery. As
discussed in the Results section, the extensive somatic mu-
tations found in the IgD1GC subpopulation relative to the
remaining subpopulations analyzed correlate with the fre-
quency of hybrid VH gene detection (Table I). Also, we
and others have demonstrated previously that large inser-
tions and deletions can result during somatic mutation (46),
suggesting a propensity of the somatic mutation machinery
to produce gross alterations in the DNA sequence (34, 47).
There are also numerous accounts of lymphoma-associated
translocations involving V sequences possibly related to the
genetic alterations that occur during somatic mutation.
Translocation of a portion of the VDJ element with an up-
stream V gene at a region of homology between the two
genes would result in a hybrid VDJ element identical to the
observations here. An important recent study from Sale and
Neuberger has demonstrated that in a somatically mutating
Burkitt’s lymphoma cell line that was transfected to over-
express terminal deoxynucleotidyl-transferase (TdT), the
mutating regions of the V genes become peppered with
short untemplated nucleotide insertions that are not found
in the C regions (67). This analysis suggests single- or dou-
ble-strand breaks in the mutating V genes that could facili-
tate a homologous recombination event through attack of
an upstream donor V gene by the free end or ends of the
mutating recipient. Greater mutation activity would cause
more free ends to be generated, leading to increased re-
combination.
Synopsis of Findings
Three key considerations in this report included: (a) B
lymphocytes derived from the clonal expansion of the same
founder can be identified by the highly unique junction of
the V, D, and J gene elements; (b) antigen-activated B cells
undergo a massive clonal expansion; and (c) the differential
pattern of somatic mutations provides a simple assay to
compare the many different progeny of the original
founder. In this study, somatic mutation represents a cellu-
lar process that leaves a permanent and progressive mark on
the various affected sequences that can be phylogenetically
analyzed. The possibility that seven highly similar but mu-
tationally different CP1 progeny using VH4-34, and seven
highly similar but differentially mutated VH4-61 clones
(VH4-61 was the hybrid donor) in the same reaction tube
could randomly come together to form hybrid VH se-
quences by PCR–splicing by overlap extension (SOE) or
other experimental artifacts is extremely unlikely. Similarly,
the pair of CP2 sister hybrids could only have formed in a1892 Receptor Revision of Immunoglobulin Heavy Chains in Humans
somatic process. The differential and shared mutations of
the various hybrid clones relative to each other and the re-
maining 58 CP1 clones or 75 CP2 clones, plus the phylo-
genetic analyses, indicate that these clones arose by receptor
revision in the periphery. The evidence at hand leaves only
one good scenario for the origin of these seven clonal hy-
brid recombinants: these hybrid clones were derived by
secondary recombination of a portion of a germline VH4-
61 gene into the already mutated VH4-34/D3-10/JH3 gene
of a CP1 founder or into the VH4-34/D-D fusion/JH6
gene of a CP2 founder, followed by additional clonal ex-
pansion and somatic hypermutation of the hybrid clono-
types and the other founder derivatives. The detection of
hybrid VH recombinants may only be a fraction of the con-
tribution of VH gene recombination to the peripheral rep-
ertoire, as this activity could also occur involving: (a) com-
plete VH gene replacements, (b) deletion or disruption of
the original rearrangement with secondary rearrangement
on the same allele (with cryptic D elements) or second al-
lele activation, and (c) JH gene replacement, as suggested by
the overrepresentation of JH6 in the IgD1GC cells. The is-
sue of RAG mediation of these events is still unresolved
and will require additional study.
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